Abiopharma

New Form ARS - OptimizeRx Corp <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001213900-26-049699 <b>Size:</b> 498 KB

New Form DEF 14A - OptimizeRx Corp <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001213900-26-049698 <b>Size:</b> 10 MB

New Form ARS - Q32 Bio Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-193970 <b>Size:</b> 6 MB

New Form S-8 - Cartesian Therapeutics, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001453687-26-000084 <b>Size:</b> 228 KB

New Form ARS - Foghorn Therapeutics Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-193958 <b>Size:</b> 2 MB

New Form DEFA14A - Q32 Bio Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-193953 <b>Size:</b> 499 KB

New Form 3 - MKDWELL Tech Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-019753 <b>Size:</b> 3 KB

New Form DEFA14A - Foghorn Therapeutics Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-193948 <b>Size:</b> 337 KB

New Form 8-K/A - Pyxis Oncology, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-193940 <b>Size:</b> 160 KB <br />Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form ARS - Unicycive Therapeutics, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001213900-26-049695 <b>Size:</b> 2 MB